About
ProSciento provides comprehensive scientific and operational expertise in the design and management of all facets of clinical drug and device development for diabetes. ProSciento’s services and client-specific programs are initiated from a deep scientific expertise in disease pathophysiology, drug classes, methodologies and nearly two decades of experience in clinical research, development and regulatory strategies exclusively for metabolic diseases.
![Specialized Expertise to Drive Advances in Diabetes Drug and Device Development thumbnail](https://prosciento.com/wp-content/uploads/2021/12/thumbnail-8.png)
Recommended Materials
![Specialized Expertise to Drive Advances in Diabetes Drug and Device Development thumbnail](https://prosciento.com/wp-content/uploads/2022/04/pharmacodynamics_novel_insulin_dimer.jpg)
Articles
A randomized, single ascending dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel insulin dimer
![Specialized Expertise to Drive Advances in Diabetes Drug and Device Development thumbnail](https://prosciento.com/wp-content/uploads/2022/01/pub-1.png)
Articles
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
![Specialized Expertise to Drive Advances in Diabetes Drug and Device Development thumbnail](https://prosciento.com/wp-content/uploads/2022/01/text-book-thumbnail.png)
Textbooks
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development
Related Solutions
![Automated Glucose Clamp Techniques thumbnail](https://prosciento.com/wp-content/uploads/2023/08/specialized-methods-automated-glucose-clamp.jpg)
Specialized Methods
![Diabetes thumbnail](https://prosciento.com/wp-content/uploads/2023/08/our-metabolic-focus-diabetes-thumbnail.jpg)